WAM
AYTU icon

Warberg Asset Management’s AYTU BioPharma AYTU Stock Holding History

Warberg Asset Management’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,250
Closed -$12K – 277
2022
Q3 		$12K Buy
+3,250
New +$24.7K ﹤0.01% 225

Other funds holding AYTU

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return
ACM
Allred Capital Management Dallas, Texas $275M AUM 18.19% 1-Year Est. Return

Warberg Asset Management's AYTU Position: Q4 2022 in Review

Warberg Asset Management sold out of AYTU BioPharma (AYTU) in Q4 2022, closing a stake of 3,250 shares — an estimated $12K sold.

Warberg Asset Management first reported a position in AYTU in Q3 2022 and held it in 1 quarter. The position peaked at $12K in Q3 2022. 36 funds tracked by Wall St. Rank hold AYTU as of Q4 2022.

  • Warberg Asset Management reported no remaining AYTU BioPharma position as of Q4 2022 after selling out during the quarter.
  • Warberg Asset Management sold 3,250 AYTU BioPharma shares in Q4 2022, an estimated $12K.
  • Warberg Asset Management first reported a position in AYTU BioPharma in Q3 2022 and held it in 1 quarter.
  • Warberg Asset Management's AYTU BioPharma position peaked at $12K in Q3 2022.
  • 36 funds tracked by Wall St. Rank held AYTU BioPharma as of Q4 2022.

Based on Warberg Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.